Active Video Games on Physical Activity (Main Trial)

March 30, 2023 updated by: Amy Lu, Northeastern University

The Narrative Effect of Active Video Games on Long-term Moderate-to-Vigorous Physical Activity (Main Trial)

The purpose of the study is to test the effects of different versions of active video games (AVGs) on body composition, cardiometabolic risks, and cognitive functions among overweight/obese children over 6 months.

Study Overview

Detailed Description

The study aims to explore the effects of narrative-enhanced AVG on (1) body composition, (2) cardiometabolic risks, and (3) cognitive functioning among overweight/obese 8-12 years old children over 6 months.

A total of 210 children will be recruited from Tufts Floating Hospital, Boston Children's Hospital, and Martha Eliot Health Center. The investigators divided the participants into three groups to evaluate the effect of using active game consoles and stories to motivate children to exercise: A third of them have standard clinical care only; a third of them have the same standard clinical care plus an Xbox and active games; the remaining third of them have the same standard clinical care, an Xbox and active games, plus the stories delivered to their Xbox consoles.

Each child, accompanied by their guardian, will be asked to visit the Northeastern University Exercise Science Laboratory over the 6-month period. Blood samples, body composition (using Dual-energy X-ray absorptiometry, or DEXA Scan), and cognitive and affective evaluations of the active video games (AVGs) will be collected. Additionally, parents will be asked to fill out questionnaires related to their child's physical activity behaviors. Children would also be required to wear two accelerometers (essentially, a "smart watch" or activity tracker) on their wrist and waist for 7 consecutive days after the three visits within the 6 months.

Study Type

Interventional

Enrollment (Actual)

135

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Northeastern University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 8-to-12-year-old
  • Being overweight or obese (BMI% >=85)
  • Speak and understand English
  • Are willing and able to complete all measures
  • Equal numbers of both genders will be recruited
  • One child per household will be eligible to participate

Exclusion Criteria:

  • Not between 8 and 12
  • Not being overweight or obese
  • Do not speak and understand English
  • Have medical or physical problems that prevent them from playing AVGs, such as epilepsy
  • Use orthopedic devices

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Care Only
A third of the participants will have standard clinical care only.
Each clinic will provide standard clinical care to the participants.
Experimental: Care + AVG
A third of the participants will have the same standard clinical care plus an Xbox and active games.
Each clinic will provide standard clinical care to the participants.
The investigators would expect children to play active video games as a way to reduce their sedentary activities and increase their moderate and vigorous physical activities.
Experimental: Care + AVG + Narratives
A third of the participants will have the same standard clinical care, an Xbox and active games, plus the stories delivered to their Xbox consoles.
Each clinic will provide standard clinical care to the participants.
The investigators would expect children to play active video games as a way to reduce their sedentary activities and increase their moderate and vigorous physical activities.
The investigators would expect the animated cartoon narratives to motivate children to play more active video games as a way to reduce their sedentary activities and increase their moderate and vigorous physical activities.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in objective child physical activity
Time Frame: 6 months
Physical activity will be measured with two 7-day accelerometer worn on the wrist and hip after three visits over 4-6 weeks, including minutes/day MVPA total. Physical activity and time spent in moderate to vigorous physical activity will be measured by two triaxial accelerometer (Actigraph Link and Actigraph GT3X+, Actigraph, Ft. Walton Beach, FL). Children will be asked to wear them for 7 full days during periods.
6 months
Changes in fat%
Time Frame: 6 months
Measured through dual-energy X-ray absorptiometry (DEXA) scan by GE Lunar Prodigy (GE Healthcare, Chicago, IL).
6 months
Changes in lean tissue%
Time Frame: 6 months
Measured through dual-energy X-ray absorptiometry (DEXA) scan by GE Lunar Prodigy (GE Healthcare, Chicago, IL).
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI%
Time Frame: 6 months
The investigators plan to use the weight in kilograms and height in meters from the DEXA scan and children's birthdays and sex to calculate their BMI% using the CDC Calculator.
6 months
Fasting Insulin
Time Frame: 6 months
Analysis of the plasma samples will be performed using dedicated Enzyme-Linked Immunosorbent Assay (ELISA) kits.
6 months
Fasting Glucose
Time Frame: 6 months
Analysis of the plasma samples will be performed using dedicated Enzyme-Linked Immunosorbent Assay (ELISA) kits.
6 months
Lipid
Time Frame: 6 months
Analysis of the serum samples will be performed using dedicated Enzyme-Linked Immunosorbent Assay (ELISA) kits.
6 months
C-reactive protein (CRP)
Time Frame: 6 months
Analysis of the serum samples will be performed using dedicated Enzyme-Linked Immunosorbent Assay (ELISA) kits.
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sustained Attention
Time Frame: 6 months
Response time will be measured by the Psychomotor Vigilance Task
6 months
Working Memory
Time Frame: 6 months
Response time will be measured by the Delayed Match-to-Sample Task
6 months
Working Memory
Time Frame: 6 months
Response accuracy will be measured by the Delayed Match-to-Sample Task
6 months
Inhibitory Control
Time Frame: 6 months
Response time will be measured by the Stroop Test
6 months
Inhibitory Control
Time Frame: 6 months
Response accuracy will be measured by the Stroop Test
6 months
Physical Activity Motivation
Time Frame: 6 months
Physical Activity Motivation will be measured by the Physical Activity Motivation scale through self-report
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 25, 2019

Primary Completion (Actual)

May 22, 2022

Study Completion (Actual)

May 22, 2022

Study Registration Dates

First Submitted

October 2, 2019

First Submitted That Met QC Criteria

October 3, 2019

First Posted (Actual)

October 4, 2019

Study Record Updates

Last Update Posted (Actual)

March 31, 2023

Last Update Submitted That Met QC Criteria

March 30, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • R01DK109316 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Inactivity in Children

Clinical Trials on Standard clinical care

Subscribe